UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 560

Sortiert nach

UP-02.227 A Possibility of Prostate Cancer Chemoprevention by Diet

Urology (Ridgewood, N.J.), 2011, Vol.78 (3), p.S340-S340

Akaza, H

2011

Volltextzugriff (PDF)

Incidence of venous thromboembolism following major abdominal surgery: a multi‐center, prospective epidemiological study in Japan

Journal of thrombosis and haemostasis, 2006-03, Vol.4 (3), p.581-586

2006

Volltextzugriff (PDF)

Cross-boundary Cancer Studies at the University of Tokyo: View from the world of science and reason

Japanese journal of clinical oncology, 2014-02, Vol.44 Suppl 1 (suppl 1), p.i3-i5

Akaza, Hideyuki

2014

Volltextzugriff (PDF)

Docetaxel Plus Prednisolone for the Treatment of Metastatic Hormone-refractory Prostate Cancer: A Multicenter Phase II Trial in Japan

Japanese journal of clinical oncology, 2008-05, Vol.38 (5), p.365-372

2008

Volltextzugriff (PDF)

Efficacy and safety of axitinib versus sorafenib in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from the global randomized Phase 3 AXIS trial

Japanese journal of clinical oncology, 2013-06, Vol.43 (6), p.616-628

2013

Volltextzugriff (PDF)

Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan

Japanese journal of clinical oncology, 2014-10, Vol.44 (10), p.969-981

2014

Volltextzugriff (PDF)

Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling

Oncogene, 2009-01, Vol.28 (2), p.297-305

2009

Volltextzugriff (PDF)

Real-time Elastography for the Diagnosis of Prostate Cancer: Evaluation of Elastographic Moving Images

Japanese journal of clinical oncology, 2009-06, Vol.39 (6), p.394-398

2009

Volltextzugriff (PDF)

Comparisons of Percent Equol Producers between Prostate Cancer Patients and Controls: Case-controlled Studies of Isoflavones in Japanese, Korean and American Residents

Japanese journal of clinical oncology, 2004-02, Vol.34 (2), p.86-89

2004

Volltextzugriff (PDF)

Cross-boundary cancer studies at the University of Tokyo: Surviving cancer in Asia: introduction

Japanese journal of clinical oncology, 2014-02, Vol.44 Suppl 1 (suppl 1), p.i1-i2

2014

Volltextzugriff (PDF)

Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis

Carcinogenesis (New York), 2007-11, Vol.28 (11), p.2398-2403

2007

Volltextzugriff (PDF)

Phase III trial of everolimus in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from RECORD-1

Japanese journal of clinical oncology, 2011-01, Vol.41 (1), p.17-24

2011

Volltextzugriff (PDF)

Phase I/II study of S-1 in combination with sorafenib for metastatic renal cell carcinoma

Annals of oncology, 2015-09, Vol.26 (9), p.1871-1876

2015

Volltextzugriff (PDF)

Adjuvant goserelin improves clinical disease‐free survival and reduces disease‐related mortality in patients with locally advanced or localized prostate cancer

BJU international, 2004-01, Vol.93 (1), p.42-46

Akaza, H.

2004

Volltextzugriff (PDF)

2549 Treatment patterns in patients (pts) with metastatic castrationresistant prostate cancer (mCRPC) previously treated with docetaxel (DOC)-based chemotherapy (CT): PROXIMA 1-year analysis

European journal of cancer (1990), 2015-09, Vol.51, p.S492-S493

2015

Volltextzugriff (PDF)

Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers

Prostate cancer and prostatic diseases, 2009-09, Vol.12 (3), p.247-252

2009

Volltextzugriff (PDF)

Fifth Joint Meeting of J-CaP and CaPSURE: advancing the global understanding of prostate cancer and its management

Japanese journal of clinical oncology, 2012-03, Vol.42 (3), p.226-236

2012

Volltextzugriff (PDF)

Advanced prostate cancer treatment guidelines: a global perspective; trends of hormone therapy in Japan

BJU international, 2004-12, Vol.94 (s3), p.5-5

Akaza, H.

2004

Volltextzugriff (PDF)

Is Daidzein Non-metabolizer a High Risk for Prostate Cancer? A Case-controlled Study of Serum Soybean Isoflavone Concentration

Japanese journal of clinical oncology, 2002-08, Vol.32 (8), p.296-300

2002

Volltextzugriff (PDF)

Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer

Japanese journal of clinical oncology, 2012-09, Vol.42 (9), p.825-830

2012

Volltextzugriff (PDF)

Current Status of Endocrine Therapy for Prostate Cancer in Japan—Analysis of Primary Androgen Deprivation Therapy on the Basis of Data Collected by J-CaP

Japanese journal of clinical oncology, 2007-10, Vol.37 (10), p.775-781

2007

Volltextzugriff (PDF)

Sixth joint meeting of J-CaP and CaPSURE--a multinational perspective on prostate cancer management and patient outcomes

Japanese journal of clinical oncology, 2013-07, Vol.43 (7), p.756-766

2013

Volltextzugriff (PDF)

The eighth Asia cancer forum: seeking to advance the outcomes of the UN summit: 'global health as the key to a new paradigm in cancer research'

Japanese journal of clinical oncology, 2012-12, Vol.42 (12), p.1222-1231

2012

Volltextzugriff (PDF)

7165 POSTER Sunitinib (SU) Pharmacokinetic (PK)-Pharmacodynamic (PD) Modeling With Respect to Safety and Efficacy Endpoints in Asian Patients With Gastrointestinal Stromal Tumour (GIST) or Renal Cell Carcinoma (RCC) in Pursuit of a Therapeutic Window

European journal of cancer (1990), 2011, Vol.47, p.S525-S525

2011

Volltextzugriff (PDF)

Superior Anti-tumor Efficacy of Bicalutamide 80 mg in Combination with a Luteinizing Hormone-releasing Hormone (LHRH) Agonist Versus LHRH Agonist Monotherapy as First-line Treatment for Advanced Prostate Cancer: Interim Results of a Randomized Study in Japanese Patients

Japanese journal of clinical oncology, 2004-01, Vol.34 (1), p.20-28

2004

Volltextzugriff (PDF)

1 – 25 von 560

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(426)
Mit Volltextzugriff
(392)

Publikationsform

Sprache

Englisch
(427)
Japanisch
(228)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(400)
Male
(313)
Science & Technology
(259)
Life Sciences & Biomedicine
(256)
Middle Aged
(195)
Aged
(183)
Female
(164)
Adult
(119)
Oncology
(119)
Biological And Medical Sciences
(104)
Medical Sciences
(91)
Urology & Nephrology
(85)
Aged, 80 And Over
(74)
Animals
(58)
Prostatic Neoplasms - Drug Therapy
(57)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(52)
Japan
(52)
Prostate Cancer
(44)
Urinary Bladder Neoplasms - Pathology
(43)
Drug Administration Schedule
(42)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

UP-02.227 A Possibility of Prostate Cancer Chemoprevention by Diet

Incidence of venous thromboembolism following major abdominal surgery: a multi‐center, prospective epidemiological study in Japan

Cross-boundary Cancer Studies at the University of Tokyo: View from the world of science and reason

Docetaxel Plus Prednisolone for the Treatment of Metastatic Hormone-refractory Prostate Cancer: A Multicenter Phase II Trial in Japan

Efficacy and safety of axitinib versus sorafenib in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from the global randomized Phase 3 AXIS trial

Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan

Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling

Real-time Elastography for the Diagnosis of Prostate Cancer: Evaluation of Elastographic Moving Images

Comparisons of Percent Equol Producers between Prostate Cancer Patients and Controls: Case-controlled Studies of Isoflavones in Japanese, Korean and American Residents

Cross-boundary cancer studies at the University of Tokyo: Surviving cancer in Asia: introduction

Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis

Phase III trial of everolimus in metastatic renal cell carcinoma: subgroup analysis of Japanese patients from RECORD-1

Phase I/II study of S-1 in combination with sorafenib for metastatic renal cell carcinoma

Adjuvant goserelin improves clinical disease‐free survival and reduces disease‐related mortality in patients with locally advanced or localized prostate cancer

2549 Treatment patterns in patients (pts) with metastatic castrationresistant prostate cancer (mCRPC) previously treated with docetaxel (DOC)-based chemotherapy (CT): PROXIMA 1-year analysis

Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers

Fifth Joint Meeting of J-CaP and CaPSURE: advancing the global understanding of prostate cancer and its management

Advanced prostate cancer treatment guidelines: a global perspective; trends of hormone therapy in Japan

Is Daidzein Non-metabolizer a High Risk for Prostate Cancer? A Case-controlled Study of Serum Soybean Isoflavone Concentration

Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer

Current Status of Endocrine Therapy for Prostate Cancer in Japan—Analysis of Primary Androgen Deprivation Therapy on the Basis of Data Collected by J-CaP

Sixth joint meeting of J-CaP and CaPSURE--a multinational perspective on prostate cancer management and patient outcomes

The eighth Asia cancer forum: seeking to advance the outcomes of the UN summit: 'global health as the key to a new paradigm in cancer research'

7165 POSTER Sunitinib (SU) Pharmacokinetic (PK)-Pharmacodynamic (PD) Modeling With Respect to Safety and Efficacy Endpoints in Asian Patients With Gastrointestinal Stromal Tumour (GIST) or Renal Cell Carcinoma (RCC) in Pursuit of a Therapeutic Window

Superior Anti-tumor Efficacy of Bicalutamide 80 mg in Combination with a Luteinizing Hormone-releasing Hormone (LHRH) Agonist Versus LHRH Agonist Monotherapy as First-line Treatment for Advanced Prostate Cancer: Interim Results of a Randomized Study in Japanese Patients

Suchergebnisse filtern